MD
MD
DYSTROPHY
• Causes
• Inheritance
• Dominant genes
• Recessive gene
Depends on the age when symptoms appear, and the
types of symptoms that develop.
• Risk
• Because these are inherited disorders, risk
include a family history of muscular dystrophy
● How Many People Are Affected
● It is estimated that between 50,000 -250,000
are affected annually. 1 per 3500 live male births
• Muscular dystrophy is a
heterogeneous group of inherited
by progressive
disorders degenerative muscle
recognized
weakness and loss of muscle tissue
(started in childhood).
• Affect muscles strength and action.
• Generalized or localized.
• Skeletal muscle and other organs
may involve
common
▫ Scapulohumeral
type • Diagnosis
rare ▫ Same clinical as
DMD/BMD carriers
▫ Moderately elevated
CPK
• Natural history
▫ Slow progression
▫ After onset > 20 y:
contracture &
disability
▫ Rarely significant
scoliosis
•T
r
e
a
Fascioscapulohumeral Muscular
Dystrophy
• Etiology • Clinical
manifestation
▫ Autosomal dominant
▫ Age of onset: late
▫ Gene defect (FRG1) childhood/ early adult
▫ No cardiac, CNS
▫ Chromosome 4q35 involvement
• Epidemiology ▫ Winging scapula decreased
▫ Markedly
▫ Female > male flexion &
shoulder
abduction
▫ Horizontal clavicles
• Muscle weakness
▫ face, shoulder, upper arm
• Sparing
▫ Deltoid
▫ Distal pectoralis major
▫ Erector spinae
• “Popeye”
appearance
▫ Lack of
▫facial mobility
Incomplete eye
closure
▫ Pouting lips
▫ Transverse
smile
▫ Absence of
eye and forehead
wrinkles
POPEYE ARMS
• Diagnosis
▫ PE, muscle biopsy
• Stiffness of joint
• Congenital hip
dislocation,
subluxation
• Achillis tendon
contracture, talipes
equinovarus
• Scoliosis
Diagnosis
Muscle Bx: Perimysial and endomysial fibrosis
Treatment
Physical therapy
Orthosis
Soft tissue release
Osteotomy
Oculopharyngeal Muscular
Dystrophy
• Autosomal dominant
• Age of onset: 3rd decade
• Ptosis in middle life
• Pharyngeal involvement
▫ Dysarthria
▫ Dysphasia
▫ Repetitive regurgitation
▫ Frequently choking
Myotonic Muscular Dystrophy
HATCHET FACIES
`Classical form' of the disease is seen in
adolescent or early adult life with variable
presenting features.
• Muscular weakness,
•myotonia,
•mental retardation,
•cataract,
•neonatal problems
•18% remain asymptomatic.
Summary
Clinical DMD LGMD FSMD DD CMD
Age of 3-6 y 2nd decade 2nd decade 20-77 y At/ after birth
onset